1. Academic Validation
  2. Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia

Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia

  • J Bone Miner Metab. 2016 Nov;34(6):662-667. doi: 10.1007/s00774-015-0713-z.
Eun Sook Kim 1 Su Yeon Kim 1 Ji Young Lee 1 Je Ho Han 1 Tae Seo Sohn 2 Hyun Shik Son 3 Sung-Dae Moon 4
Affiliations

Affiliations

  • 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsoo-ro, Bupyeong-gu, Incheon, 403-720, Republic of Korea.
  • 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijungbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 137-701, Republic of Korea. [email protected].
  • 3 Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijungbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 137-701, Republic of Korea.
  • 4 Division of Endocrinology and Metabolism, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsoo-ro, Bupyeong-gu, Incheon, 403-720, Republic of Korea. [email protected].
Abstract

The calcium-sensing receptor (CaSR) is a G-protein-coupled receptor that plays an essential role in maintaining calcium homeostasis. In the present study, we analyzed the CaSR gene in a Korean family with familial hypocalciuric hypercalcemia (FHH). Genetic studies were performed by direct sequence analysis of the CaSR gene in genomic DNA obtained from peripheral leukocytes. A novel heterozygous G to T substitution at nucleotide position 1711 in exon 6, resulting in the G571W mutation, was identified in the CaSR gene in a 26-year-old female with asymptomatic hypercalcemia, a low calcium/creatinine clearance ratio, and normal intact parathyroid hormone. To study CaSR expression, the mutation was introduced by site-directed mutagenesis into a wild-type (WT) CaSR-expressing pCR3.1 vector, and COS-7 cells were transfected with either the WT or mutant CaSR-containing vector. Transfected cells loaded with Fura-2/AM, a fluorescent indicator of Ca2+, were assessed for CaSR function by the change in intracellular calcium [as measured by the 340 nm/380 nm fluorescence intensity ratio (F340/F380)] made in response to challenge with extracellular Ca2+. Both WT and G571W cells had equivalent amounts of CaSR protein in the cell membrane. However, after challenge with extracellular Ca2+, cells transfected with G571W CaSR responded with a lower F340/F380 ratio than those transfected with WT CaSR and showed decreased sensitivity to extracellular Ca2+ concentrations. The G571W mutation had therefore impaired the CaSR function. In conclusion, we identified a novel loss-of-function mutation, G571W, in the CaSR gene in a Korean family with FHH.

Keywords

Autosomal dominant; Calcium-sensing receptor; Familial hypocalciuric hypercalcemia.

Figures